Gut vascular barrier in the pathogenesis and resolution of Crohn's disease: A novel link from origination to therapy

Clin Immunol. 2023 Aug:253:109683. doi: 10.1016/j.clim.2023.109683. Epub 2023 Jul 3.

Abstract

The gut vascular barrier (GVB) is the deepest layer of the gut barrier. It mainly comprised gut vascular endothelial cells, enteric glial cells, and pericytes. The GVB facilitates nutrient absorption and blocks bacterial translocation through its size-restricted permeability. Accumulating evidence suggests that dysfunction of this barrier correlates with several clinical pathologies including Crohn's disease (CD). Significant progress has been made to elucidate the mechanism of GVB dysfunction and to confirm the participation of disrupted GVB in the course of CD. However, further analyses are required to pinpoint the specific roles of GVB in CD pathogenesis. Many preclinical models and clinical trials have demonstrated that various agents are effective in protecting the GVB integrity and thus providing a potential CD treatment strategy. Through this review, we established a systemic understanding of the role of GVB in CD pathogenesis and provided novel insights for GVB-targeting strategies in CD treatment.

Keywords: Crohn's disease; Gut vascular barrier; Microbiota; Mucosal immunity; Probiotics.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Crohn Disease* / drug therapy
  • Crohn Disease* / microbiology
  • Endothelial Cells
  • Humans
  • Intestinal Mucosa / microbiology